Usefulness of abdominal ultrasonography in the analysis of endoscopic activity in patients with Crohn's disease: Changes following treatment with immunomodulators and/or anti-TNF antibodies

Journal of Crohn's and Colitis

Volumn 8, Issue 9, 2014, Pages 1079-1087

  Moreno, Nadia ^a   Ripollés, Tomás ^a   Paredes, José María ^a   Ortiz, Inmaculada ^a   Martínez, María Jesús ^a   López, Antonio ^a   Delgado, Fructuoso ^a   Moreno Osset, Eduardo ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Abdominal ultrasound; Crohn's disease; Mucosal healing

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; IMMUNOMODULATING AGENT; INFLIXIMAB; MERCAPTOPURINE; TUMOR NECROSIS FACTOR INHIBITOR; C REACTIVE PROTEIN; SONOVUE; IMMUNOLOGIC FACTOR; IMMUNOLOGICAL ADJUVANT; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL ULTRASONOGRAPHY; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; ECHOGRAPHY; ENDOSCOPY; FEMALE; HUMAN; ILEOCOLONOSCOPY; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; COLONOSCOPY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HEALING; INTESTINE MUCOSA; INTESTINE WALL; LOGISTIC REGRESSION ANALYSIS; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THICKNESS; TREATMENT OUTCOME; TREATMENT RESPONSE; ANTAGONISTS AND INHIBITORS; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; PATHOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; CROHN DISEASE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOLOGIC FACTORS; INTESTINAL MUCOSA; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY, DOPPLER, COLOR; YOUNG ADULT;

EID: 84906789873     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.02.008     Document Type: Article

References (28)

1. Rutgeerts P., Diamond R.H., Bala M., Olson A., Lichtenstein G.R., Bao W., et al. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease. Gastrointest Endosc 2006, 63:433-442.
2. Hommes D.W., Van Deventer S.J.H. Endoscopy in inflammatory bowel diseases. Gastroenterology 2004, 126:1561-1573.
3. Chan G., Fefferman D.S., Farrell R.J. Endoscopic assessment of inflammatory bowel disease: colonoscopy/esophagogastroduodenoscopy. Gastroenterol Clin 2012, 41:271-290.
4. Baert F., Moortgat L., Van Assche G., Caenepeel P., Vergauwe P., De Vos M., et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010, 138:463-468.
5. FrØslie K.F., Jahnsen J., Moum B.A., Vatn M.H., IBSEN Group Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007, 133:412-422.
6. Navaneethan U., Parasa S., Venkatesh P.G., Trikudanathan G., Shen B. Prevalence and risk factors for colonic perforation during colonoscopy in hospitalized inflammatory bowel disease patients. J Crohns Colitis 2011, 5:189-195.
7. Navaneethan U., Kochhar G., Phull H., Venkatesh P.G.K., Remzi F.H., Kiran R.P., et al. Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients. J Crohns Colitis 2012, 6:470-475.
8. Shah H.A., Paszat L.F., Saskin R., Stukel T.A., Rabeneck L. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology 2007, 132:2297-2303.
9. Benell O., Lapidus A., Hellers G. Recurrence after colectomy in Crohn's colitis. Dis Colon Rectum 2001, 44:647-654.
10. Panés J., Bouzas R., Chaparro M., Garcia-Sánchez V., Gisbert J.P., Martínez de Guereñu B., et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment Pharmacol Ther 2011, 34:125-145.
11. Horsthuis K., Bipat S., Bennink R.J., Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: metaanalysis of prospective studies. Radiology 2008, 247:64-79.
12. Fraquelli M., Colli A., Cassaza G., Paggi S., Colucci A., Massironi S., et al. Role of US in detection of Crohn disease: meta-analysis. Radiology 2005, 236:95-101.
13. Ripollés T., Martínez M.J., Paredes J.M., Blanc E., Flors L., Delgado F. Crohn disease: correlation of findings at contrast-enhanced US with severity at endoscopy. Radiology 2009, 253:241-248.
14. Migaleddu V., Scanu A.M., Quaia E., Rocca P.C., Dore M.P., Scanu D., et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in Crohn's disease. Gastroenterology 2009, 137:43-61.
15. Rispo A., Bucci L., Pesce G., Sabbatini F., De Palma G.D., Grassia R., et al. Bowel sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis 2006, 12:486-490.
16. Castiglione F., Bucci L., Pesce G., De Palma G.D., Camera L., Cipolletta F., et al. Oral contrast-enhanced sonography for the diagnosis and grading of postsurgical recurrence of Crohn's disease. Inflamm Bowel Dis 2008, 14:1240-1245.
17. Calabrese E., Petruzziello C., Onali S., Condino G., Zorzi F., Pallone F. Biancone L severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings. Inflamm Bowel Dis 2009, 15:1635-1642.
18. Castiglione F., Testa A., Rea M., De Palma G.D., Diaferia M., Musto D., et al. Transmural healing evaluated by bowel sonography in patients with Crohn's disease on maintenance treatment with biologics. Inflamm Bowel Dis 2013, 19:1928-1934.
19. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989, 170:2-6.
20. Dignass A., Van Assche G., Lindsay J.O., Lémann M., Söderholm J., Colombel J.F., et al. European Crohn's and Colitis Organisation (ECCO). The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2010, 4:28-62.
21. Mary J.Y., Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Estudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989, 30:983-989.
22. Hébuterne X., Lémann M., Bouhnik Y., Dewit O., Dupas J.L., Mross M., et al. Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol. Gut 2013, 62:201-208.
23. Patriquin H.B., Garcier J.M., Lafortune M., Yazbeck S., Russo P., Jequier S., et al. Appendicitis in children and young adults: Doppler sonographic-pathologic correlation. AJR Am J Roentgenol 1996, 166:629-633.
24. Paredes J.M., Ripollés T., Cortés X., Martínez M.J., Barrachina M., Gómez F., et al. Abdominal sonographic changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease. Dig Dis Sci 2010, 55:404-410.
25. Neurath M.F., Travis S.P. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 2012, 61:1619-1635.
26. Rutgeerts P., Van Assche G., Sandborn W.J., Wolf D.C., Geboes K., Colombel J.F., et al. Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND Trial. Gastroenterology 2012, 142:1102-1111.
27. Thomson M., Rao P., Berger L., Rawat D. Graded compression and power Doppler ultrasonography versus endoscopy to assess paediatric Crohn disease activity pre- and posttreatment. J Pediatr Gastroenterol Nutr 2012, 54:404-408.
28. Rimola J., Rodriguez S., García-Bosch O., Ordás I., Ayala E., Aceituno M., et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009, 58:1113-1120.